1.  McDonagh J (December 2014).

"Statin-related cognitive impairment in the real world: you'll live

longer, but you might not like it".  JAMA Internal Medicine.  174  (12):
1889.  doi:10.1001/jamainternmed.2014.5376. PMID 25347692.
2. ^ "FDA Drug Safety Communication: Important safety label changes to cholesterol-lowering statin
drugs".  U.S. Food and Drug Administration  (FDA). 19 January 2016.  Archivedfrom the original on
13 October 2019. Retrieved 25 March  2018.
3. ^ Backes JM, Ruisinger JF, Gibson CA, Moriarty PM (January–February 2017). "Statin-associated
muscle symptoms-Managing the highly intolerant". Journal of Clinical Lipidology. 11 (1): 24–
33.  doi:10.1016/j.jacl.2017.01.006.  PMID  28391891.
4. ^ Newman CB, Preiss D, Tobert JA, Jacobson TA, Page RL, Goldstein LB, et al. (2019). "Statin
Safety and Associated Adverse Events: A Scientific Statement From the American Heart
Association".  Arteriosclerosis, Thrombosis, and Vascular Biology. 39 (2): e38–
e81.  doi:10.1161/ATV.0000000000000073.  PMID  30580575.
5. ^ Rull G, Henderson R (20 January 2015). "Rhabdomyolysis and Other Causes of Myoglobinuria".
Retrieved 6 May  2015.
6. ^ Mendes P, Robles PG, Mathur S (2014).  "Statin-induced rhabdomyolysis: a comprehensive
review of case reports". Physiother Can.  66  (2): 124–32.  doi:10.3138/ptc.2012-
65.  PMC 4006404. PMID 24799748.
7. ^ Potgieter M, Pretorius E, Pepper MS (March 2013). "Primary and secondary coenzyme Q10
deficiency: the role of therapeutic supplementation".  Nutrition Reviews.  71  (3): 180–
88.  doi:10.1111/nure.12011.  PMID  23452285.
8. ^ Tan JT, Barry AR (June 2017). "Coenzyme Q10 supplementation in the management of statin-
associated myalgia".  American Journal of Health-System Pharmacy. 74 (11): 786–
93.  doi:10.2146/ajhp160714.  PMID  28546301.
9. ^ Link E, Parish S, Armitage J, Bowman L, Heath S, Matsuda F, et al. (August 2008). "SLCO1B1
variants and statin-induced myopathy – a genomewide study".  The New England Journal of
Medicine. 359 (8): 789–99. doi:10.1056/NEJMoa0801936.  PMID  18650507.
10. ^ Jump up to:a b Graham DJ, Staffa JA, Shatin D, Andrade SE, Schech SD, La Grenade L, et al.
(December 2004). "Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering
drugs".  JAMA. 292 (21): 2585–90.  doi:10.1001/jama.292.21.2585.  PMID  15572716.
11. ^ Backman JT, Filppula AM, Niemi M, Neuvonen PJ (January 2016). "Role of Cytochrome P450
2C8 in Drug Metabolism and Interactions".  Pharmacological Reviews  (Review). 68 (1): 168–
241.  doi:10.1124/pr.115.011411.  PMID  26721703.
12. ^ Jump up to:a b Hanai J, Cao P, Tanksale P, Imamura S, Koshimizu E, Zhao J, et al. (December
2007). "The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle
toxicity". The Journal of Clinical Investigation.  117  (12): 3940–
51.  doi:10.1172/JCI32741.  PMC 2066198. PMID 17992259.
13. ^ Teichtahl AJ, Brady SR, Urquhart DM, Wluka AE, Wang Y, Shaw JE, et al. (February 2016).
"Statins and tendinopathy: a systematic review". The Medical Journal of Australia. 204 (3): 115–
21.e1.  doi:10.5694/mja15.00806. PMID 26866552.
14. ^ Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, et al. (February 2010).
"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin
trials".  Lancet.  375  (9716): 735–42. doi:10.1016/S0140-6736(09)61965-6.  PMID  20167359.
15. ^ Chou R, Dana T, Blazina I, Daeges M, Jeanne TL (November 2016). "Statins for Prevention of
Cardiovascular Disease in Adults: Evidence Report and Systematic Review for the US Preventive
Services Task Force".  JAMA  (Review). 316 (19): 2008–
24.  doi:10.1001/jama.2015.15629. PMID 27838722.
16. ^ Jump up to:a b c d Rochlani Y, Kattoor AJ, Pothineni NV, Palagiri RD, Romeo F, Mehta JL (October
2017). "Balancing Primary Prevention and Statin-Induced Diabetes Mellitus Prevention". The
American Journal of Cardiology (Review).  120  (7): 1122–
28.  Bibcode:1981AmJC...48..728H.  doi:10.1016/j.amjcard.2017.06.054. PMID 28797470.
17. ^ He Y, Li X, Gasevic D, Brunt E, McLachlan F, Millenson M, et al. (16 October 2018). "Statins
and Multiple Noncardiovascular Outcomes: Umbrella Review of Meta-analyses of Observational
Studies and Randomized Controlled Trials". Annals of Internal Medicine. 169(8): 543–
53.  doi:10.7326/M18-0808.  PMID  30304368